Gilles Salles, MD, PhD, is professor of Hematology and Medicine at the University of Lyon, and Head of the Department of Hematology at the Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, in Pierre-Bénite, France.
Professor Salles obtained his MD, as well as his PhD in differentiation, genetics, and immunology from Claude Bernard Lyon-1 University. He completed further training in oncology and also worked as a researcher at the Dana-Farber Cancer Institute of Harvard Medical School in Boston, Massachusetts, USA.
For more than 20 years, Professor Salles has been especially interested in the clinical and biological study of lymphoma. The primary focus of his work is on the description and validation of prognostic factors and clinical trials in indolent lymphomas.
His research team, “Clinical and Experimental Models of Lymphomagenesis,” at the Cancer Research Center of Lyon, is examining several aspects of lymphoma biology: T- and B-cell models, signaling, genomic biology of the splenic marginal zone, and prognostic factors.
Previously, Professor Salles chaired the Scientific Committee of the Adult Lymphoma Study Group and is now the chair of the Lymphoma Study Association, a European cooperative group. He is also a member of several international societies, including the American Society of Hematology.
Professor Salles is the author of more than 300 publications, including articles in international peer-reviewed journals such as Blood, Journal of Clinical Oncology, The Lancet, Haematologica, Lancet Oncology, and Leukemia and Lymphoma